Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Testicular Neoplasms × Testosterone × Clear all

Phase

Phase 2/3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Testicular Neoplasms 1 Muscle Weakness 1 Multiple Endocrine Neoplasia Type 1 1 Motor Activity 1 Metabolic Syndrome 1

Interventions

testosterone undecanoate 1 Testosterone 1 Paclitaxel 1 Filgrastim 1 Etoposide 1 Cisplatin 1 Castor Oil 1 Bleomycin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02991209 2020-03-06

Einstein

Rigshospitalet, Denmark

Phase 2/3 Completed

Testicular Neoplasms, Metabolic Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡